Future of Executive Summary Skin and Skin Structure Infections (SSSI) (Infectious Disease) Treatment Market: Size and Share Dynamics CAGR Value The global Skin and Skin Structure Infections (SSSI) (Infectious Disease) Treatment market size was valued at USD 13.03 billion in 2025 and is expected to reach USD 25.02 billion by 2033, at a CAGR of 8.50% during the forecast period This Skin and...

The global leishmaniasis treatment market is gaining momentum as healthcare organizations, governments, and pharmaceutical companies intensify efforts to combat neglected tropical diseases. Leishmaniasis is a parasitic disease caused by protozoa of the Leishmania species and is transmitted through the bites of infected sandflies. The disease remains a significant public health concern in...

The growing burden of infectious diseases, increasing hospital-acquired infections, and rising awareness regarding advanced treatment options are contributing significantly to the expansion of the systemic antibiotics market. Healthcare systems across developed and emerging economies are focusing on improving infection management and strengthening antimicrobial therapies. The Systemic...